Skip to main content


Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: Suppressed diversity of survivin splicing in active rheumatoid arthritis

Fig. 5

Correlations between clinical parameters of RA and survivin splice variants in BM after rituximab (RTX) treatment. Correlations between survivin splice variants and a change of CD19+ B cells, b levels of rheumatoid factor (RF) and c Disease Activity Score (DAS28) in 23 patients after RTX treatment. 1Correlation to survivin splice variants before RTX treatment. 2Correlation to survivin splice variants after RTX treatment. Correlations were calculated with Spearman’s analysis. dCT values were used for the individual splice variants, and RQ values were used for the survivin-2B/WT and survivin-ΔEx3/WT ratios. WT wild type

Back to article page